Kyoto Breast Cancer Research Network   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Kyoto Japan (2015)

Organization Overview

First Clinical Trial
2017
NCT03430479
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Kyoto Breast Cancer Research Network

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6